Specialty drug costs skyrocketed to $33B in Medicare Part D in 2015

Specialty drug costs skyrocketed to $33B in Medicare Part D in 2015

Source: 
Biopharma Dive
snippet: 

Brand-name specialty drugs accounted for only 1% of all prescriptions in both Medicare Part D and Medicaid, but accounted for 30% of net spending.